Jundishapur Journal of Microbiology

Published by: Kowsar

Levels of Transforming Growth Factor-Beta After Immunization of Mice With in vivo prepared Toxoplasma gondii Excretory/Secretory Proteins

Seyed Hossein Abdollahi 1 , Fateme Ayoobi 2 , Hossein Khorramdelazad 1 , Behzad Nasiri Ahmadabadi 3 , Mohammadtaghi Rezayati 3 , Mohammad Kazemi Arababadi 3 and Mohammad Zare-Bidaki 3 , *
Authors Information
1 Molecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
2 Physiology and Pharmacology Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
3 Immunology of Infectious Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
Article information
  • Jundishapur Journal of Microbiology: May 2015, 8 (5); e59855
  • Published Online: May 31, 2015
  • Article Type: Research Article
  • Received: January 24, 2014
  • Revised: April 9, 2014
  • Accepted: April 15, 2014
  • DOI: 10.5812/jjm.8(5)2015.17802

To Cite: Abdollahi S H, Ayoobi F, Khorramdelazad H, Nasiri Ahmadabadi B, Rezayati M, et al. Levels of Transforming Growth Factor-Beta After Immunization of Mice With in vivo prepared Toxoplasma gondii Excretory/Secretory Proteins, Jundishapur J Microbiol. 2015 ; 8(5):e59855. doi: 10.5812/jjm.8(5)2015.17802.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Rinaldi L, Scala A. Toxoplasmosis in livestock in Italy: an epidemiological update. Parassitologia. 2008; 50(1-2): 59-61[PubMed]
  • 2. Abdollahi SO, Arababadi MK, Hassanshahi G. Evaluation of excreted/secreted antigens derived from peritoneal of toxoplasma infected small mice to detect IgG against Toxoplasma. Pak J Biol Sci. 2009; 12(6): 530-3[PubMed]
  • 3. Nissapatorn V. Toxoplasmosis in HIV/AIDS: a living legacy. Southeast Asian J Trop Med Public Health. 2009; 40(6): 1158-78[PubMed]
  • 4. Hide G, Morley EK, Hughes JM, Gerwash O, Elmahaishi MS, Elmahaishi KH, et al. Evidence for high levels of vertical transmission in Toxoplasma gondii. Parasitology. 2009; 136(14): 1877-85[DOI][PubMed]
  • 5. Blokzijl ML. Human immunodeficiency virus infection in childhood. Ann Trop Paediatr. 1988; 8(1): 1-17[PubMed]
  • 6. Jongert E, Roberts CW, Gargano N, Forster-Waldl E, Petersen E. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz. 2009; 104(2): 252-66[PubMed]
  • 7. Angus CW, Klivington-Evans D, Dubey JP, Kovacs JA. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis. 2000; 181(1): 317-24[DOI][PubMed]
  • 8. El-Malky M, Shaohong L, Kumagai T, Yabu Y, Noureldin MS, Saudy N, et al. Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL/6 mice. Microbiol Immunol. 2005; 49(7): 639-46[PubMed]
  • 9. Liu KY, Zhang DB, Wei QK, Li J, Li GP, Yu JZ. Biological role of surface Toxoplasma gondii antigen in development of vaccine. World J Gastroenterol. 2006; 12(15): 2363-8[PubMed]
  • 10. Daryani A, Hosseini AZ, Dalimi A. Immune responses against excreted/secreted antigens of Toxoplasma gondii tachyzoites in the murine model. Vet Parasitol. 2003; 113(2): 123-34[DOI]
  • 11. Abdollahi SH, Ayoobi F, Khorramdelazad H, Hassanshahi G, Ahmadabadi BN, Rezayati M, et al. Interleukin-10 Serum Levels after Vaccination with In Vivo Prepared Toxoplasma gondii Excreted/Secreted Antigens. Oman Med J. 2013; 28(2): 112-5[DOI][PubMed]
  • 12. Costa-Silva TA, Borges MM, Galhardo CS, Pereira-Chioccola VL. Immunization with excreted/secreted proteins in AS/n mice activating cellular and humoral response against Toxoplasma gondii infection. Acta Trop. 2012; 124(3): 203-9[DOI][PubMed]
  • 13. Hafid J, Vincent N, Flori P, Bellete B, Raberin H, Sung RT. Production of antibodies in murine mucosal immunization with Toxoplasma gondii excreted/secreted antigens. Vet Parasitol. 2005; 128(1-2): 23-8[DOI][PubMed]
  • 14. Darcy F, Deslee D, Santoro F, Charif H, Auriault C, Decoster A, et al. Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii. Parasite Immunol. 1988; 10(5): 553-67[PubMed]
  • 15. Chen JL, Ge YY, Zhang J, Qiu XY, Qiu JF, Wu JP, et al. The dysfunction of CD4(+)CD25(+) regulatory T cells contributes to the abortion of mice caused by Toxoplasma gondii excreted-secreted antigens in early pregnancy. PLoS One. 2013; 8(7)[DOI][PubMed]
  • 16. Odenthal-Schnittler M, Tomavo S, Becker D, Dubremetz JF, Schwarz RT. Evidence for N-linked glycosylation in Toxoplasma gondii. Biochem J. 1993; 291: 713-21
  • 17. Arababadi MK, Mosavi R, Khorramdelazad H, Yaghini N, Zarandi ER, Araste M, et al. Cytokine patterns after therapy with Avonex(R), Rebif(R), Betaferon(R) and CinnoVex in relapsing-remitting multiple sclerosis in Iranian patients. Biomark Med. 2010; 4(5): 755-9[DOI][PubMed]
  • 18. Ahmadabadi BN, Hassanshahi G, Arababadi MK, Leanza C, Kennedy D. The IL-10 promoter polymorphism at position -592 is correlated with susceptibility to occult HBV infection. Inflammation. 2012; 35(3): 818-21[DOI][PubMed]
  • 19. Kehrl JH. Transforming growth factor-beta: an important mediator of immunoregulation. Int J Cell Cloning. 1991; 9(5): 438-50[DOI][PubMed]
  • 20. Karimi-Googheri M, Daneshvar H, Nosratabadi R, Zare-Bidaki M, Hassanshahi G, Ebrahim M, et al. Important roles played by TGF-beta in hepatitis B infection. J Med Virol. 2014; 86(1): 102-8[DOI][PubMed]
  • 21. Wagner A, Forster-Waldl E, Garner-Spitzer E, Schabussova I, Kundi M, Pollak A, et al. Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice. Int J Parasitol. 2009; 39(4): 465-72[DOI][PubMed]
  • 22. Kasper L, Courret N, Darche S, Luangsay S, Mennechet F, Minns L, et al. Toxoplasma gondii and mucosal immunity. Int J Parasitol. 2004; 34(3): 401-9[DOI][PubMed]
  • 23. D'Angelillo A, De Luna E, Romano S, Bisogni R, Buffolano W, Gargano N, et al. Toxoplasma gondii Dense Granule Antigen 1 stimulates apoptosis of monocytes through autocrine TGF-beta signaling. Apoptosis. 2011; 16(6): 551-62[DOI][PubMed]
  • 24. Makino M, Uemura N, Moroda M, Kikumura A, Piao LX, Mohamed RM, et al. Innate immunity in DNA vaccine with Toxoplasma gondii-heat shock protein 70 gene that induces DC activation and Th1 polarization. Vaccine. 2011; 29(10): 1899-905[DOI][PubMed]
  • 25. Yan HK, Yuan ZG, Petersen E, Zhang XX, Zhou DH, Liu Q, et al. Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1. Exp Parasitol. 2011; 128(1): 38-43[DOI][PubMed]
  • 26. Cong H, Mui EJ, Witola WH, Sidney J, Alexander J, Sette A, et al. Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201. Vaccine. 2011; 29(4): 754-62[DOI][PubMed]
  • 27. Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Grzybowski M, et al. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Vaccine. 2011; 29(4): 821-30[DOI][PubMed]
  • 28. Prigione I, Facchetti P, Lecordier L, Deslee D, Chiesa S, Cesbron-Delauw MF, et al. T cell clones raised from chronically infected healthy humans by stimulation with Toxoplasma gondii excretory-secretory antigens cross-react with live tachyzoites: characterization of the fine antigenic specificity of the clones and implications for vaccine development. J Immunol. 2000; 164(7): 3741-8[PubMed]
  • 39. Quan JH, Zhou W, Cha GH, Choi IW, Shin DW, Lee YH. Kinetics of IL-23 and IL-12 secretion in response to Toxoplasma gondii antigens from THP-1 monocytic cells. Korean J Parasitol. 2013; 51(1): 85-92[DOI][PubMed]
  • 30. Rahmah N, Anuar A. Comparison of three forms of antigens in the demonstration of cell-mediated immune response in murine toxoplasmosis. Biochemical and Biophysical Research Communications. 1992; 189(2): 640-4[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments